ClinicalTrialStartPulse / report
TRB Chemedica International SA: Not applicable (device, behavioral) study started recruiting, 80 planned (Dry Eye Disease)
TRB Chemedica International SA: Not applicable (device, behavioral) study started recruiting, 80 planned (Dry Eye Disease). Its enrollment of 80 is above the median of 80 (51st percentile). Dated 6 days ago, it is inside the fresh trigger window. Score 80/100. As of 2026-11-03, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 80 · 51th percentile of 8,570 ClinicalTrialStartPulse records · 1.0x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | TRB Chemedica International SA |
| Sponsor type | Industry (pharma, biotech, medtech) |
| Study | Efficacy and Safety of BUFY01 Versus SVS20 in the Treatment of Dry Eye Disease |
| NCT ID | NCT05865379 |
| Phase | Not applicable (device, behavioral) |
| Status | recruiting |
| Conditions | Dry Eye Disease |
| Intervention types | device |
| Target enrollment | 80 |
| Site countries | Belgium, France |
| Posted | 2023-05-18 |
| Planned start | 2026-10-26 |
| Event | Started recruiting |
| Event date | 2026-10-26 |
| Last update posted | 2026-10-29 |
| enrollment percentile | 51th of 8,570 (median 80, 1.0x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch TRB Chemedica International SA
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Unlock TRB Chemedica International SA + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-10-29
- Data refreshed: 2026-11-03
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Tue, 03 Nov 2026 05:11:05 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: TRB Chemedica International SA and 6,377 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,377
- TRB Chemedica International SA's enrollment: 51st percentile of 8,570 records
- Timing: High: dated in the last 7 days
- Estimated pipeline if you contact every NONUS peer: $1,275,400 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
80 / 100 Score
- Posted in the last two weeks.
- Industry sponsor (buys outsourced services).
- Just started recruiting: sites, recruitment and supply are active.
What is the ClinicalTrialStartPulse record for TRB Chemedica International SA?
TRB Chemedica International SA's Not applicable (device, behavioral) study (NCT05865379) in Dry Eye Disease, first posted 2023-05-18: started recruiting (2026-10-26), in an update posted 2026-10-29.
How does TRB Chemedica International SA compare to other ClinicalTrialStartPulse records?
Its enrollment of 80 sits in the upper half (51th percentile) of 8,570 records; the median is 80. It is fresh: dated 6 days ago, inside the window where early outreach matters most. Its Score of 80/100 puts it among the stronger signals in this feed.
TRB Chemedica International SA vs. top 3 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| TRB Chemedica International SA | NONUS | 80 | 51st | 2026-10-29 |
| A.M.I. Agency for Medical Innovations GmbH | NONUS | 100 | 60th | 2026-10-30 |
| Axomove | NONUS | 184 | 74th | 2026-10-29 |
| CareDx | NONUS | 200 | 77th | 2026-10-29 |
Related records
ClinicalTrialStartPulse: Not applicable (device, behavioral) ClinicalTrialStartPulse: Outside the US only
How to monitor TRB Chemedica International SA and peer not applicable (device, behavioral) records
Get new ClinicalTrialStartPulse records like TRB Chemedica International SA by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.